Sit Investment Associates Inc Novartis Ag Transaction History

Sit Investment Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $223,435 - $253,357	-2,415 Reduced 35.18%	4,450 $449,000
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $314,918 - $365,207	-3,935 Reduced 36.44%	6,865 $632,000
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $533,990 - $590,471	-6,700 Reduced 38.29%	10,800 $945,000
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $153,972 - $169,668	1,800 Added 11.46%	17,500 $1.52 Million
Q2 2018 Jul 19, 2018	SELL	$64.91 - $73.36 $201,221 - $227,416	-3,100 Reduced 16.49%	15,700 $1.19 Million
Q1 2018 Apr 20, 2018	SELL	$70.39 - $84.15 $13,726 - $16,409	-195 Reduced 1.03%	18,800 $1.52 Million
Q3 2017 Oct 18, 2017	BUY	$74.14 - $77.27 $1.41 Million - $1.47 Million	18,995	18,995 $1.63 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.